Literature DB >> 16926752

Epidemiology of hepatitis B--clinical implications.

Jacob Alexander1, Kris V Kowdley.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16926752      PMCID： PMC1785180     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  33 in total

1.  Chronic hepatitis B.

Authors:  A S Lok; B J McMahon
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

2.  Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan.

Authors:  Sheng-Nan Lu; Chien-Hung Chen; Tsung-Ming Chen; Pei-Lun Lee; Jing-Houng Wang; Hung-Da Tung; Chao-Hung Hung; Chuan-Mo Lee; Chi-Sin Changchien
Journal:  Vaccine       Date:  2005-08-30       Impact factor: 3.641

3.  Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers.

Authors:  Jin-Town Wang; Cha-Ze Lee; Pei-Jer Chen; Teh-Hong Wang; Ding-Shinn Chen
Journal:  Transfusion       Date:  2002-12       Impact factor: 3.157

4.  Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.

Authors:  Yaw-Sen Chen; Chih-Chi Wang; Vanessa H de Villa; Shih-Hor Wang; Yu-Fan Cheng; Tung-Liang Huang; Bruno Jawan; King-Wah Chiu; Chao-Long Chen
Journal:  Clin Transplant       Date:  2002-12       Impact factor: 2.863

5.  Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program.

Authors:  R Harpaz; B J McMahon; H S Margolis; C N Shapiro; D Havron; G Carpenter; L R Bulkow; R B Wainwright
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

6.  Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.

Authors:  I Bica; B McGovern; R Dhar; D Stone; K McGowan; R Scheib; D R Snydman
Journal:  Clin Infect Dis       Date:  2001-01-23       Impact factor: 9.079

7.  Hepatitis B virus genotypes in the United States: results of a nationwide study.

Authors:  Chi-Jen Chu; Emmet B Keeffe; Steven-Huy Han; Robert P Perrillo; Albert D Min; Consuelo Soldevila-Pico; William Carey; Robert S Brown; Velimir A Luketic; Norah Terrault; Anna S F Lok
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

8.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

Authors:  Chloe L Thio; Eric C Seaberg; Richard Skolasky; John Phair; Barbara Visscher; Alvaro Muñoz; David L Thomas
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

9.  High prevalence of occult hepatitis B in Baltimore injection drug users.

Authors:  Michael Torbenson; Rajesh Kannangai; Jacquie Astemborski; Steffanie A Strathdee; David Vlahov; David L Thomas
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

10.  Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.

Authors:  Ferdinand W N M Wit; Gerrit Jan Weverling; Jan Weel; Suzanne Jurriaans; Joep M A Lange
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226
View more
  3 in total

1.  Risk factors of hepatitis B transmission in northern Palestine: a case - control study.

Authors:  Zaher Nazzal; Inam Sobuh
Journal:  BMC Res Notes       Date:  2014-03-28

2.  THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA.

Authors:  Uleanya Nwachinemere Davidson; Nwokoye Ikenna Chidiebele; Emodi Ifeoma Josephine; Obidike Egbuna Olakunle; Ikefuna Anthony Nnaemeka; Eze Jude Chijioke; Ndu Ikenna Kingsley
Journal:  Afr J Infect Dis       Date:  2016-05-01

3.  Serological markers and risk factors associated with Hepatitis B virus infection among Federal Capital Territory prison inmates, Nigeria: Should we be concerned?

Authors:  Chioma Cindy Dan-Nwafor; Ikeola Adeoye; Kehinde Aderemi; Martins Onuoha; Elizabeth Adedire; Adebobola Bashorun; Damaris Osunkwo; Saheed Gidado; Muhammad Balogun; Suleiman Idris; Ibrahim Ade-Yusuf; Ekpedeme Udom; Patrick Nguku
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.